|
End-of-day quote
Canadian Securities Exchange
28/10/2026
|
5-day change | 1st Jan Change | ||
| 0.0250 CAD | -16.67% |
|
0.00% | -66.67% |
| Market Cap | 32.68L 23.37L 20.94L 19.31L 17.48L 22Cr 33.21L 2.3Cr 91.93L 12Cr 87.72L 85.85L 37Cr | P/E 2024 |
-1.85x | P/E 2025 | -3.69x |
|---|---|---|---|---|---|
| Enterprise Value | 47.74L 34.14L 30.58L 28.21L 25.53L 33Cr 48.51L 3.37Cr 1.34Cr 17Cr 1.28Cr 1.25Cr 54Cr | EV / Sales 2024 |
0.67x | EV / Sales 2025 | 0.89x |
| Free-Float |
82.94% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| HERB | End-of-day quote | |
Canadian Securities Exchange
| HERB | Delayed | |
|
OTC Markets
| LUFFF | Delayed | |
|
Deutsche Boerse AG
| HA9 | Delayed |
| 1 day | -16.67% | ||
| 1 month | -28.57% | ||
| 3 months | -28.57% | ||
| 6 months | -58.33% | ||
| Current year | -66.67% |
| 1 week | 0.02 |  | 0.03 |
| 1 month | 0.02 | | 0.04 |
| Current year | 0.02 | | 0.12 |
| 1 year | 0.02 | | 0.13 |
| 3 years | 0.02 | | 0.13 |
| 5 years | 0.02 | | 0.25 |
| 10 years | 0.02 | | 9.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Philip Campbell
CEO | Chief Executive Officer | - | 15/05/2020 |
Jason Vandenberg
DFI | Director of Finance/CFO | 49 | 18/01/2022 |
Aron Tegenfeldt
PRN | Corporate Officer/Principal | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Philip Campbell
BRD | Director/Board Member | - | 15/05/2020 |
Drew Malcolm
BRD | Director/Board Member | - | 24/06/2020 |
Herb Dhaliwal
CHM | Chairman | 73 | 23/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/09/26 | Buy | Chairman | 2,00,000 | 0.1530% | ||
| 14/09/26 | Buy | Chairman | 1,00,000 | 0.0779% | ||
| 02/09/26 | Buy | Chairman | 1,00,000 | 0.0779% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -16.67% | 0.00% | -68.75% | -50.00% | 23.29L | |
| +6.63% | +8.10% | +67.50% | +145.20% | 1,14800Cr | |
| +1.53% | +6.76% | +47.22% | +89.01% | 65TCr | |
| +1.68% | +2.10% | +27.80% | +109.31% | 51TCr | |
| +0.73% | +2.47% | +53.85% | +68.96% | 38TCr | |
| +3.83% | -2.37% | +68.14% | +42.32% | 35TCr | |
| +2.38% | +4.27% | +33.81% | +57.95% | 29TCr | |
| +2.26% | +3.47% | +5.21% | +28.92% | 26TCr | |
| +1.97% | +5.11% | +57.74% | +76.14% | 24TCr | |
| +4.03% | +7.84% | +40.49% | +116.14% | 20TCr | |
| Average | +1.37% | +1.25% | +33.30% | +68.40% | 40.37TCr | |
| Weighted average by Cap. | +3.72% | +1.50% | +49.58% | +95.97% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 99.23L 70.97L 63.57L 58.64L 53.07L 68Cr 1.01Cr 7Cr 2.79Cr 35Cr 2.66Cr 2.61Cr 112.02Cr | 1.21Cr 86.71L 77.66L 71.65L 64.84L 83Cr 1.23Cr 8.55Cr 3.41Cr 43Cr 3.25Cr 3.18Cr 136.86Cr |
| Net income | -27.73L -19.83L -17.76L -16.39L -14.83L -19Cr -28.18L -1.96Cr -78L -9.88Cr -74.43L -72.84L -31Cr | -18.41L -13.17L -11.8L -10.88L -10L -13Cr -18.71L -1.3Cr -51.79L -6.56Cr -49.42L -48.37L -21Cr |
| Net Debt | 13.75L 10L 9L 8L 7L 9.36Cr 13.97L 96.94L 38.67L 4.9Cr 36.9L 36.12L 16Cr | 15.05L 10.77L 10L 9L 8L 10Cr 15.3L 1.06Cr 42.34L 5.37Cr 40.41L 39.55L 17Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | CA$0.0250 | 0.00% | 1,08,000 |
| 28/26/28 | CA$0.0250 | -16.67% | 91,000 |
| 27/26/27 | CA$0.0300 | +20.00% | 5,000 |
| 26/26/26 | CA$0.0250 | 0.00% | 14,100 |
| 23/26/23 | CA$0.0250 | 0.00% | 1,57,000 |
- Stock Market
- Stocks
- HERB Stock
Select your edition
All financial news and data tailored to specific country editions
